These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24610925)

  • 81. Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease.
    Navaneethan SD; Beddhu S
    Nephrol Dial Transplant; 2009 Apr; 24(4):1260-6. PubMed ID: 19033255
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Association Between Serum High-Density Lipoprotein Cholesterol Levels and Progression of Chronic Kidney Disease: Results From the KNOW-CKD.
    Nam KH; Chang TI; Joo YS; Kim J; Lee S; Lee C; Yun HR; Park JT; Yoo TH; Sung SA; Lee KB; Oh KH; Kim SW; Lee J; Kang SW; Choi KH; Ahn C; Han SH;
    J Am Heart Assoc; 2019 Mar; 8(6):e011162. PubMed ID: 30859896
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Plasma fibrinogen associates independently with total and cardiovascular mortality among subjects with normal and reduced kidney function in the general population.
    Stack AG; Donigiewicz U; Abdalla AA; Weiland A; Casserly LF; Cronin CJ; Nguyen HT; Hannigan A
    QJM; 2014 Sep; 107(9):701-13. PubMed ID: 24633257
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Very High High-Density Lipoprotein Cholesterol Levels and Cardiovascular Mortality.
    Liu C; Dhindsa D; Almuwaqqat Z; Sun YV; Quyyumi AA
    Am J Cardiol; 2022 Mar; 167():43-53. PubMed ID: 35039162
    [TBL] [Abstract][Full Text] [Related]  

  • 85. HDL in CKD: how good is the "good cholesterol?".
    de Boer IH; Brunzell JD
    J Am Soc Nephrol; 2014 May; 25(5):871-4. PubMed ID: 24610924
    [No Abstract]   [Full Text] [Related]  

  • 86. Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.
    Zewinger S; Kleber ME; Rohrer L; Lehmann M; Triem S; Jennings RT; Petrakis I; Dressel A; Lepper PM; Scharnagl H; Ritsch A; Thorand B; Heier M; Meisinger C; de Las Heras Gala T; Koenig W; Wagenpfeil S; Schwedhelm E; Böger RH; Laufs U; von Eckardstein A; Landmesser U; Lüscher TF; Fliser D; März W; Meinitzer A; Speer T
    Eur Heart J; 2017 May; 38(20):1597-1607. PubMed ID: 28379378
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: a meta-analysis.
    Li WJ; Chen XM; Nie XY; Zhang J; Cheng YJ; Lin XX; Wu SH
    Clinics (Sao Paulo); 2015 Apr; 70(4):301-11. PubMed ID: 26017799
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The Relationship of Kidney Function, Cardiovascular Morbidity, and All-Cause Mortality: a Prospective Primary Care Cohort Study.
    Korhonen PE; Kiiski S; Kautiainen H; Ojanen S; Tertti R
    J Gen Intern Med; 2023 Jun; 38(8):1834-1842. PubMed ID: 36544069
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Impact of renal function on the prognostic value of mineral metabolism in patients with chronic ischaemic heart disease patients with chronic ischaemic heart disease.
    Aceña Á; Pello-Lázaro AM; Martínez-Milla J; González-Lorenzo Ó; Tarín N; Cristóbal C; Blanco-Colio LM; Martín-Ventura JL; Huelmos A; López-Castillo M; Alonso J; Gutiérrez-Landaluce C; López Bescós L; Alonso-Pulpón L; González-Parra E; Egido J; Mahíllo-Fernández I; Lorenzo Ó; González-Casaus ML; Tuñón J
    Clin Investig Arterioscler; 2022; 34(1):1-9. PubMed ID: 34876305
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Hypertension and low HDL cholesterol were associated with reduced kidney function across the age spectrum: a collaborative study.
    Odden MC; Tager IB; Gansevoort RT; Bakker SJ; Fried LF; Newman AB; Katz R; Satterfield S; Harris TB; Sarnak MJ; Siscovick D; Shlipak MG
    Ann Epidemiol; 2013 Mar; 23(3):106-11. PubMed ID: 23313266
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The impact of normal range estimated glomerular filtration rate on mortality in selected patients undergoing coronary angiography - a long-term follow-up.
    Zornitzki L; Sadon S; Wenkert A; Steinvil A; Konigstein M; Ben-Shoshan J; Kliuk-Ben Bassat O; Sirota S; Halkin A; Bazan S; Finkelstein A; Banai S; Arbel Y
    Coron Artery Dis; 2021 Jun; 32(4):302-308. PubMed ID: 33229938
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease.
    Marsche G; Heine GH; Stadler JT; Holzer M
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32967334
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Serum Albumin and Cerebro-cardiovascular Mortality During a 15-year Study in a Community-based Cohort in Tanushimaru, a Cohort of the Seven Countries Study.
    Umeki Y; Adachi H; Enomoto M; Fukami A; Nakamura S; Nohara Y; Nakao E; Sakaue A; Tsuru T; Morikawa N; Fukumoto Y
    Intern Med; 2016; 55(20):2917-2925. PubMed ID: 27746426
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Longitudinal lipid trends and adverse outcomes in patients with CKD: a 13-year observational cohort study.
    Tsai CW; Huang HC; Chiang HY; Chung CW; Chang SN; Chu PL; Kuo CC
    J Lipid Res; 2019 Mar; 60(3):648-660. PubMed ID: 30642880
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Associations of total homocysteine and kidney function with all-cause and cause-specific mortality in hypertensive patients: a mediation and joint analysis.
    Ding C; Li J; Wei Y; Fan W; Cao T; Chen Z; Shi Y; Yu C; Yuan T; Zhao P; Zhou W; Yu C; Wang T; Zhu L; Huang X; Bao H; Cheng X
    Hypertens Res; 2024 Jun; 47(6):1500-1511. PubMed ID: 38438721
    [TBL] [Abstract][Full Text] [Related]  

  • 96. HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype.
    Shroff R; Speer T; Colin S; Charakida M; Zewinger S; Staels B; Chinetti-Gbaguidi G; Hettrich I; Rohrer L; O'Neill F; McLoughlin E; Long D; Shanahan CM; Landmesser U; Fliser D; Deanfield JE
    J Am Soc Nephrol; 2014 Nov; 25(11):2658-68. PubMed ID: 24854267
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Low GFR amplifies the association between coronary three-vessel disease and all-cause mortality.
    Piscitelli P; D'Errico MM; Mirijello A; Santoliquido M; Salvatori M; Vigna C; Marchese N; Vendemiale G; Copetti M; Pontremoli R; De Cosmo SA
    Nutr Metab Cardiovasc Dis; 2022 Feb; 32(2):402-409. PubMed ID: 34893408
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Circulating Sclerostin Levels Are Positively Related to Coronary Artery Disease Severity and Related Risk Factors.
    Frysz M; Gergei I; Scharnagl H; Smith GD; Zheng J; Lawlor DA; Herrmann M; Maerz W; Tobias JH
    J Bone Miner Res; 2022 Feb; 37(2):273-284. PubMed ID: 34738659
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Circulating CD5L is associated with cardiovascular events and all-cause mortality in individuals with chronic kidney disease.
    Castelblanco E; Sarrias MR; Betriu À; Soldevila B; Barranco-Altirriba M; Franch-Nadal J; Valdivielso JM; Bermudez-Lopez M; Groop PH; Fernández E; Alonso N; Mauricio D
    Aging (Albany NY); 2021 Oct; 13(19):22690-22709. PubMed ID: 34629330
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Impact of eGFR rate on 1-year all-cause mortality in patients with stable coronary artery disease.
    De Luca L; Cappadona F; Temporelli PL; Gonzini L; Ledda A; Raisaro A; Viazzi F; Gabrielli D; Colivicchi F; Gulizia MM; Pontremoli R;
    Eur J Intern Med; 2022 Jul; 101():98-105. PubMed ID: 35513990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.